Table 2: Association of alleles with creatinine-adjusted cadmium concentration.
|
P-value |
|||
Locus (N missing) |
Gene and coordinates* |
Alleles or haplotypes |
Log2-transformed |
Not transformed |
rs352038 (6) |
CXCL3 4:74052981 |
C/T |
0.58‡ |
0.74‡ |
rs2234693 |
ESR1 6:151842200 |
C/T |
0.18‡ |
0.44‡ |
rs9340799 |
ESR1 6:151842246 |
A/G |
0.99‡ |
0.45‡ |
rs3020314 |
ESR1 6:151949537 |
C/T |
0.62‡ |
0.64‡ |
rs1255998 |
ESR2 14:64227153 |
C/G |
0.76‡ |
0.77‡ |
rs944050 |
ESR2 14:64233327 |
A/G |
0.47‡ |
0.97‡ |
rs4775936 (12) |
CYP19A1 15:51243825 |
C/T |
0.34‡ |
0.05‡ |
rs28366003 (6) |
MT2A 16:56608579 |
A/G |
0.15‡ |
0.10‡ |
rs3918249 (9) |
MMP9 20:46009497 |
C/T |
0.59‡ |
0.29‡ |
rs12011793 |
AR X:67698249 |
C/T |
0.48‡ |
0.62‡ |
rs12011518 |
AR X:67713194 |
G/T |
0.94‡ |
0.88‡ |
ESR1Hap§ |
|
CAC |
0.14† |
0.02† |
|
CAT |
0.74† |
0.14† |
|
|
CGC |
0.83† |
0.65† |
|
|
CGT |
0.17† |
0.26† |
|
|
TAC |
0.44† |
0.51† |
|
|
TAT |
0.70† |
0.47† |
|
|
TGC |
0.94† |
0.85† |
|
|
TGT |
0.06† |
0.10† |
|
ESR2Hapd |
|
CA |
0.46† |
0.82† |
|
GA |
0.47† |
0.18† |
|
|
GG |
0.22† |
0.74† |
|
ARHapd |
|
CG |
0.67† |
0.54† |
|
CT |
0.87† |
0.58† |
|
|
TG |
0.35† |
0.73† |
|
|
TT |
- |
- |
*Chromosome number: Position in bp based on Genome Reference Consortium Human Build 38 patch release 7 [29]. †Independent group t-test; ‡Analysis of variance; §Haplotype based on the SNPs located within the corresponding gene.